Quarterly report pursuant to Section 13 or 15(d)

Accrued Issuable Equity (As Restated) (Details Textual)

v3.20.4
Accrued Issuable Equity (As Restated) (Details Textual)
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Accrued Issuable Equity (As Restated) (Details Textual)  
Warrants to purchase shares of common stock | shares 28,935
Common stock exercise price per share | $ / shares $ 5.28
Convertible notes issuance | $ $ 172,248
Restricted stock price | $ / shares $ 7.36
Dividends percentage rate 0.00%
Volatility percentage 207.00%
Fair value adjustment of warrants | $ $ 35,149
Minimum [Member]  
Accrued Issuable Equity (As Restated) (Details Textual)  
Expected terms 4 years 2 months 30 days
Risk-free interest rate 0.28%
Maximum [Member]  
Accrued Issuable Equity (As Restated) (Details Textual)  
Expected terms 4 years 6 months
Risk-free interest rate 0.33%